United States Generic Drugs Market Report 2017

January 2017 | 108 pages | ID: UDF5B9485FDEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Generic Drugs

Revenue, means the sales value of Generic Drugs

This report studies sales (consumption) of Generic Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Teva Pharma.
• Novartis company
• Mylan
• Allergan
• Hospira
• Dr. Reddy’s Lab.
• Stada
• Greenstone
• Par Pharma
• Sun Pharmaceutical
• Aspen Pharmacare
• Fresenius
• Lupin

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Pure (Non-branded) Generics
• Branded Generics
• Super Generics

Split by applications, this report focuses on sales, market share and growth rate of Generic Drugs in each application, can be divided into

• Cardiovascular & Hypertension
• Dermatology
• Diabetes
• Rheumatology
• Oncology
• Gastrointestinal
• Others

Contents

United States Generic Drugs Market Report 2017

1 GENERIC DRUGS OVERVIEW

1.1 Product Overview and Scope of Generic Drugs
1.2 Classification of Generic Drugs
  1.2.1 Pure (Non-branded) Generics
  1.2.2 Branded Generics
  1.2.3 Super Generics
1.3 Application of Generic Drugs
  1.3.1 Cardiovascular & Hypertension
  1.3.2 Dermatology
  1.3.3 Diabetes
  1.3.4 Rheumatology
  1.3.5 Oncology
  1.3.6 Gastrointestinal
  1.3.7 Others
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Generic Drugs (2011-2021)
  1.4.1 United States Generic Drugs Sales and Growth Rate (2011-2021)
  1.4.2 United States Generic Drugs Revenue and Growth Rate (2011-2021)

2 UNITED STATES GENERIC DRUGS COMPETITION BY MANUFACTURERS

2.1 United States Generic Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Generic Drugs Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Generic Drugs Average Price by Manufactures (2015 and 2016)
2.4 Generic Drugs Market Competitive Situation and Trends
  2.4.1 Generic Drugs Market Concentration Rate
  2.4.2 Generic Drugs Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES GENERIC DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2011-2016)

3.1 United States Generic Drugs Sales and Market Share by States (2011-2016)
3.2 United States Generic Drugs Revenue and Market Share by States (2011-2016)
3.3 United States Generic Drugs Price by States (2011-2016)

4 UNITED STATES GENERIC DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

4.1 United States Generic Drugs Sales and Market Share by Type (2011-2016)
4.2 United States Generic Drugs Revenue and Market Share by Type (2011-2016)
4.3 United States Generic Drugs Price by Type (2011-2016)
4.4 United States Generic Drugs Sales Growth Rate by Type (2011-2016)

5 UNITED STATES GENERIC DRUGS SALES (VOLUME) BY APPLICATION (2011-2016)

5.1 United States Generic Drugs Sales and Market Share by Application (2011-2016)
5.2 United States Generic Drugs Sales Growth Rate by Application (2011-2016)
5.3 Market Drivers and Opportunities

6 UNITED STATES GENERIC DRUGS MANUFACTURERS PROFILES/ANALYSIS

6.1 Teva Pharma.
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Generic Drugs Product Type, Application and Specification
    6.1.2.1 Pure (Non-branded) Generics
    6.1.2.2 Branded Generics
  6.1.3 Teva Pharma. Generic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.1.4 Main Business/Business Overview
6.2 Novartis company
  6.2.2 Generic Drugs Product Type, Application and Specification
    6.2.2.1 Pure (Non-branded) Generics
    6.2.2.2 Branded Generics
  6.2.3 Novartis company Generic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.2.4 Main Business/Business Overview
6.3 Mylan
  6.3.2 Generic Drugs Product Type, Application and Specification
    6.3.2.1 Pure (Non-branded) Generics
    6.3.2.2 Branded Generics
  6.3.3 Mylan Generic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.3.4 Main Business/Business Overview
6.4 Allergan
  6.4.2 Generic Drugs Product Type, Application and Specification
    6.4.2.1 Pure (Non-branded) Generics
    6.4.2.2 Branded Generics
  6.4.3 Allergan Generic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.4.4 Main Business/Business Overview
6.5 Hospira
  6.5.2 Generic Drugs Product Type, Application and Specification
    6.5.2.1 Pure (Non-branded) Generics
    6.5.2.2 Branded Generics
  6.5.3 Hospira Generic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.5.4 Main Business/Business Overview
6.6 Dr. Reddy’s Lab.
  6.6.2 Generic Drugs Product Type, Application and Specification
    6.6.2.1 Pure (Non-branded) Generics
    6.6.2.2 Branded Generics
  6.6.3 Dr. Reddy’s Lab. Generic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.6.4 Main Business/Business Overview
6.7 Stada
  6.7.2 Generic Drugs Product Type, Application and Specification
    6.7.2.1 Pure (Non-branded) Generics
    6.7.2.2 Branded Generics
  6.7.3 Stada Generic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.7.4 Main Business/Business Overview
6.8 Greenstone
  6.8.2 Generic Drugs Product Type, Application and Specification
    6.8.2.1 Pure (Non-branded) Generics
    6.8.2.2 Branded Generics
  6.8.3 Greenstone Generic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.8.4 Main Business/Business Overview
6.9 Par Pharma
  6.9.2 Generic Drugs Product Type, Application and Specification
    6.9.2.1 Pure (Non-branded) Generics
    6.9.2.2 Branded Generics
  6.9.3 Par Pharma Generic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.9.4 Main Business/Business Overview
6.10 Sun Pharmaceutical
  6.10.2 Generic Drugs Product Type, Application and Specification
    6.10.2.1 Pure (Non-branded) Generics
    6.10.2.2 Branded Generics
  6.10.3 Sun Pharmaceutical Generic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.10.4 Main Business/Business Overview
6.11 Aspen Pharmacare
6.12 Fresenius
6.13 Lupin

7 GENERIC DRUGS MANUFACTURING COST ANALYSIS

7.1 Generic Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Generic Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Generic Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Generic Drugs Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES GENERIC DRUGS MARKET FORECAST (2016-2021)

11.1 United States Generic Drugs Sales, Revenue Forecast (2016-2021)
11.2 United States Generic Drugs Sales Forecast by Type (2016-2021)
11.3 United States Generic Drugs Sales Forecast by Application (2016-2021)
11.4 Generic Drugs Price Forecast (2016-2021)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Generic Drugs
Table Classification of Generic Drugs
Figure United States Sales Market Share of Generic Drugs by Type in 2015
Figure Pure (Non-branded) Generics Picture
Figure Branded Generics Picture
Figure Super Generics Picture
Table Application of Generic Drugs
Figure United States Sales Market Share of Generic Drugs by Application in 2015
Figure Cardiovascular & Hypertension Examples
Figure Dermatology Examples
Figure Diabetes Examples
Figure Rheumatology Examples
Figure Oncology Examples
Figure Gastrointestinal Examples
Figure Others Examples
Figure United States Generic Drugs Sales and Growth Rate (2011-2021)
Figure United States Generic Drugs Revenue and Growth Rate (2011-2021)
Table United States Generic Drugs Sales of Key Manufacturers (2015 and 2016)
Table United States Generic Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Generic Drugs Sales Share by Manufacturers
Figure 2016 Generic Drugs Sales Share by Manufacturers
Table United States Generic Drugs Revenue by Manufacturers (2015 and 2016)
Table United States Generic Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Generic Drugs Revenue Share by Manufacturers
Table 2016 United States Generic Drugs Revenue Share by Manufacturers
Table United States Market Generic Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Generic Drugs Average Price of Key Manufacturers in 2015
Figure Generic Drugs Market Share of Top 3 Manufacturers
Figure Generic Drugs Market Share of Top 5 Manufacturers
Table United States Generic Drugs Sales by States (2011-2016)
Table United States Generic Drugs Sales Share by States (2011-2016)
Figure United States Generic Drugs Sales Market Share by States in 2015
Table United States Generic Drugs Revenue and Market Share by States (2011-2016)
Table United States Generic Drugs Revenue Share by States (2011-2016)
Figure Revenue Market Share of Generic Drugs by States (2011-2016)
Table United States Generic Drugs Price by States (2011-2016)
Table United States Generic Drugs Sales by Type (2011-2016)
Table United States Generic Drugs Sales Share by Type (2011-2016)
Figure United States Generic Drugs Sales Market Share by Type in 2015
Table United States Generic Drugs Revenue and Market Share by Type (2011-2016)
Table United States Generic Drugs Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Generic Drugs by Type (2011-2016)
Table United States Generic Drugs Price by Type (2011-2016)
Figure United States Generic Drugs Sales Growth Rate by Type (2011-2016)
Table United States Generic Drugs Sales by Application (2011-2016)
Table United States Generic Drugs Sales Market Share by Application (2011-2016)
Figure United States Generic Drugs Sales Market Share by Application in 2015
Table United States Generic Drugs Sales Growth Rate by Application (2011-2016)
Figure United States Generic Drugs Sales Growth Rate by Application (2011-2016)
Table Teva Pharma. Basic Information List
Table Teva Pharma. Generic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Teva Pharma. Generic Drugs Sales Market Share (2011-2016)
Table Novartis company Basic Information List
Table Novartis company Generic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis company Generic Drugs Sales Market Share (2011-2016)
Table Mylan Basic Information List
Table Mylan Generic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Mylan Generic Drugs Sales Market Share (2011-2016)
Table Allergan Basic Information List
Table Allergan Generic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Allergan Generic Drugs Sales Market Share (2011-2016)
Table Hospira Basic Information List
Table Hospira Generic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Hospira Generic Drugs Sales Market Share (2011-2016)
Table Dr. Reddy’s Lab. Basic Information List
Table Dr. Reddy’s Lab. Generic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Dr. Reddy’s Lab. Generic Drugs Sales Market Share (2011-2016)
Table Stada Basic Information List
Table Stada Generic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Stada Generic Drugs Sales Market Share (2011-2016)
Table Greenstone Basic Information List
Table Greenstone Generic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Greenstone Generic Drugs Sales Market Share (2011-2016)
Table Par Pharma Basic Information List
Table Par Pharma Generic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Par Pharma Generic Drugs Sales Market Share (2011-2016)
Table Sun Pharmaceutical Basic Information List
Table Sun Pharmaceutical Generic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sun Pharmaceutical Generic Drugs Sales Market Share (2011-2016)
Table Aspen Pharmacare Basic Information List
Table Fresenius Basic Information List
Table Lupin Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Generic Drugs
Figure Manufacturing Process Analysis of Generic Drugs
Figure Generic Drugs Industrial Chain Analysis
Table Raw Materials Sources of Generic Drugs Major Manufacturers in 2015
Table Major Buyers of Generic Drugs
Table Distributors/Traders List
Figure United States Generic Drugs Production and Growth Rate Forecast (2016-2021)
Figure United States Generic Drugs Revenue and Growth Rate Forecast (2016-2021)
Table United States Generic Drugs Production Forecast by Type (2016-2021)
Table United States Generic Drugs Consumption Forecast by Application (2016-2021)
Table United States Generic Drugs Sales Forecast by States (2016-2021)
Table United States Generic Drugs Sales Share Forecast by States (2016-2021)